TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 27,078 | 22,787 | 28,134 |
Financial expenses | 34 | 13 | 15 |
Earnings before taxes | -1,596 | -1,240 | -102 |
EBITDA | -1,535 | -8,195 | 803 |
Total assets | 28,975 | 29,765 | 15,109 |
Current assets | 28,904 | 29,653 | 10,546 |
Current liabilities | 7,901 | 6,632 | 10,821 |
Equity capital | 21,074 | 23,123 | 4,278 |
- share capital | 15 | 16 | 15 |
Employees (average) | 129 | 93 | 40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 72.7% | 77.7% | 28.3% |
Turnover per employee | 210 | 245 | 703 |
Profit as a percentage of turnover | -5.9% | -5.4% | -0.4% |
Return on assets (ROA) | -5.4% | -4.1% | -0.6% |
Current ratio | 365.8% | 447.1% | 97.5% |
Return on equity (ROE) | -7.6% | -5.4% | -2.4% |
Change turnover | 4,713 | -6,457 | 103 |
Change turnover % | 21% | -22% | 0% |
Chg. No. of employees | 36 | 53 | 11 |
Chg. No. of employees % | 39% | 133% | 38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.